Status:
ACTIVE_NOT_RECRUITING
mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression
Lead Sponsor:
Kaiser Permanente
Conditions:
Post Partum Depression
Perinatal Depression
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Postpartum depression (PPD) is associated with significant health consequences for mothers and children, and the current COVID-19 pandemic has had a major impact on the mental health of particularly v...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Current Kaiser Permanente Permanente Northern California (KPNC) member
- Pregnant woman receiving prenatal care at KPNC
- Gestational age \<30 weeks
- Singleton pregnancy
- Self-identify as Black and/or Latina
- Moderate to moderately severe depressive symptoms (PHQ-9 score between 10 and 19) and no indication of suicidality
- Owns a device with internet access
- English- or Spanish-speaking
Exclusion
- Regular stress reduction practice with a mindfulness component (e.g., meditation or yoga more than twice a week)
- Deaf
- Blind
- Acting as gestational carrier/surrogate
Key Trial Info
Start Date :
June 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05186272
Start Date
June 14 2022
End Date
December 1 2025
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northern California
Oakland, California, United States, 94611